The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful
| Image |  |
|---|---|
| Description | scientific article published on 02 June 2010 |
| Author/s | |
| Publication date | June 2, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |